modif
locat
test
triclosan
perform
modif
frequenc
sampl
stool
urin
saliva
skin
swab
mother
everi
month
method
urin
collect
babi
addit
use
electron
data
collect
via
tablet
updat
titl
page
footer
repagin
signatur
document
approv
protocol
attach
provid
necessari
assur
trial
conduct
accord
stipul
protocol
includ
statement
regard
confidenti
accord
local
legal
regulatori
requir
principl
outlin
applic
us
feder
regul
ich
guidelin
determin
associ
infecti
diseas
load
measur
sickday
utero
age
year
growth
measur
heightforweight
zscore
determin
whether
exposur
antimicrobi
triclosan
measur
intervent
arm
decreas
infecti
diseas
load
secondari
assess
associ
infect
microbi
divers
character
microbiota
rrna
gene
sequenc
analysi
assess
associ
infect
breadth
develop
immun
system
respons
measur
type
proport
effector
memori
central
memori
cell
assess
associ
growth
microbi
divers
assess
associ
growth
breadth
develop
immun
system
respons
assess
associ
triclosan
exposur
microbi
divers
assess
associ
triclosan
exposur
breadth
develop
immun
system
respons
see
figur
see
appendix
list
studi
site
appendix
studi
contact
roster
obes
overweight
epidem
us
children
accord
center
diseas
control
prevent
cdc
today
obes
preval
quadrupl
among
obes
teenag
becom
obes
adult
potenti
suffer
gamut
weightrel
problem
physiolog
imbal
calor
intak
expenditur
explain
shift
weight
howev
diet
exercis
primari
recipi
research
attent
respect
intak
expenditur
correl
childhood
obes
much
might
expect
moreov
random
clinic
trial
address
diet
exercis
demonstr
littl
impact
childhood
bodi
mass
index
bmi
indic
even
import
difficult
modifi
hypothes
rise
childhood
obes
caus
loss
recurr
chronic
infect
modern
industri
societi
begin
utero
extend
earli
childhood
surprisingli
littl
known
sequenc
frequenc
infect
childhood
infect
metabol
toll
extrem
howev
would
disagre
infect
protect
obes
children
suffer
sever
recurr
infect
eg
children
develop
world
rare
ever
fat
industri
world
recurr
infect
cystic
fibrosi
result
heighten
rest
energi
expenditur
ree
poor
weight
gain
despit
good
calor
intak
although
extrem
may
littl
relev
averag
children
hypothesi
infect
decreas
weight
normal
children
certainli
plausibl
infect
increas
expenditur
decreas
calor
intak
degre
celsiu
elev
temperatur
result
increas
ree
fever
consider
increas
energi
expenditur
despit
similar
temperatur
curv
calor
intak
period
ill
infant
neonat
sepsi
ree
weight
gain
nonsept
neonat
cours
temperatur
ree
acut
elev
fever
nt
mean
children
lose
weight
longer
term
fact
studi
indic
rebound
weight
acut
ill
howev
chronic
infect
eg
asymptomat
hiv
bacteriuria
schistosomiasi
associ
prolong
ree
elev
elev
creactiv
protein
similarli
treatment
hepat
c
viru
hcv
result
reduct
ree
adipocytokin
may
affect
infect
exampl
erad
helicobact
pylori
prepubert
children
decreas
ghrelin
level
increas
bmi
compar
untreat
children
fact
chronic
infect
symptomat
asymptomat
like
increas
metabol
demand
constant
crosstalk
host
mechan
may
play
well
inflammatori
cytokin
suppress
appetit
affect
cell
differenti
specif
circul
tumor
necrosi
factor
tnf
inhibit
adipocyt
differenti
promot
lipolysi
manner
shortterm
infect
longterm
effect
young
children
histor
greatest
shift
popul
health
attribut
chang
genet
human
behavior
alter
infecti
diseas
incid
due
decreas
famili
size
also
link
obes
improv
hygien
expand
spectrum
vaccin
coverag
earli
antimicrobi
use
infecti
diseas
simpli
disappear
seriou
problem
children
us
industri
west
studi
document
declin
incid
rheumat
fever
scarlet
fever
poststreptococcoc
glomerulonephr
tuberculosi
epstein
barr
viru
ebv
toxoplasmosi
invas
group
b
streptococc
infect
childhood
diarrhea
append
erysiplela
otiti
media
dysenteri
h
pylori
vaccin
prevent
diseas
furthermor
infect
incid
diminish
age
infect
acquisit
rise
potenti
affect
cell
growth
differenti
overal
consequ
ecolog
shift
go
chang
like
occur
also
microbiota
human
gastrointestin
tract
consid
infectiousi
acquir
environ
gut
microbi
popul
shown
impact
varieti
metabol
process
includ
inflamm
angiogenesi
immun
insulin
resist
may
import
role
growth
rel
proport
bacteri
phyla
shown
respons
weight
chang
thu
childhood
infecti
condit
dramat
impact
gut
microbiota
least
short
term
may
well
longterm
effect
microbiota
may
well
play
role
longterm
weight
chang
hypothesi
childhood
infect
protect
obes
revolutionari
potenti
paradigm
shift
true
rais
critic
question
increas
weight
childhood
sign
good
health
diseas
one
would
argu
morbid
obes
adulthood
healthi
increas
weight
children
howev
poor
predictor
adult
obes
moreov
even
countri
socioeconom
transit
like
china
india
mexico
see
increas
childhood
weight
particularli
among
upper
classesan
observ
like
mark
improv
longev
discoveri
overweight
childhood
result
remark
progress
protect
children
prematur
death
infect
may
end
transform
concept
obes
lead
us
consid
care
modul
relationship
microbi
world
triclosan
phenol
chlorin
phenol
antibacteri
compound
found
consum
product
sinc
includ
deodor
toothpast
shave
cream
mouth
wash
clean
suppli
kitchen
utensil
toy
bed
sock
trash
bag
triclosan
regul
fda
current
conduct
review
safeti
date
triclosan
proven
reduc
plagu
gingiv
use
toothpast
evid
show
extra
benefit
health
triclosan
consum
product
demonstr
mechan
action
higher
concentr
nonspecif
lower
concentr
appear
specif
target
bacteri
fatti
acid
synthesi
antibiot
properti
led
concern
develop
antimicrobi
resist
addit
evid
triclosan
may
endocrin
disruptor
anim
model
triclosan
found
serum
urin
breast
milk
sewag
drink
water
small
amount
ban
denmark
norway
sweden
unit
kingdom
finland
probabl
reduc
microbi
divers
home
environ
triclosan
may
subtl
advers
health
effect
remain
identifi
within
cohort
studi
present
nest
intervent
random
remov
triclosancontain
clean
product
household
particip
randomli
assign
receiv
household
clean
product
either
choic
contain
triclosan
product
suppli
asneed
basi
purchas
antimicrobi
contain
product
done
presum
reduc
incid
infect
within
household
assess
incid
infecti
diseas
infant
compar
rate
arm
triclosan
use
extens
year
offwhit
odorless
tastelss
crystallin
powder
practic
insolubl
water
moder
solubl
alkalin
solut
readili
solubl
nonpolar
organ
solvent
triclosan
activ
concentr
formul
depend
primari
site
action
cytoplasm
membran
uptak
triclosan
cell
wall
well
whole
cell
diffus
primari
antimicrobi
action
triclosan
direct
toward
rna
protein
synthesi
bacteria
dna
shown
effect
low
concentr
broad
spectrum
gramneg
gramposit
bacteria
notabl
proteu
vulgari
salmonella
sp
mycobacteria
anaerob
bacteria
fungi
ammonia
produc
bacteria
yeast
dermatophyt
certain
resid
skin
bacteria
triclosan
acut
toxic
mammal
shown
tradit
toxic
test
mice
hog
rat
subacutesubchron
toxic
test
rat
rabbit
dog
baboon
rang
day
week
assess
potenti
effect
oral
dermal
applic
toxic
effect
differ
speci
rout
administr
hepat
lesion
hematolog
effect
occur
oral
administr
intub
capsul
rabbit
dog
baboon
show
episod
emesi
diarrhea
chronic
toxic
carcinogen
studi
identifi
carcinogen
potenti
treatment
level
rat
treatmentrel
tumor
found
liver
male
femal
mice
tumor
suggest
arisen
way
peroxisom
proliferatoractiv
receptor
alpha
pparalpha
activ
mode
action
consid
relev
human
numer
independ
mutagen
studi
identifi
posit
result
reproduct
studi
rat
show
effect
reproduct
perform
studi
conduct
assess
development
toxic
rat
rabbit
teratolog
effect
observ
triclosan
shown
vitro
activ
human
pregnan
x
receptor
induc
hepat
phase
enzym
vivo
caus
decreas
total
thyroxin
suggest
advers
effect
thyroid
hormon
homeostasi
howev
data
appear
question
physiolog
relev
evid
hypothyroid
effect
adjust
hypothalamopituitari
axi
decreas
triclosan
exhibit
rel
high
affin
androgen
receptor
cellbas
bioassay
exhibit
androgen
antagonist
activ
without
agonist
activ
antiandrogen
effect
demonstr
vivo
toler
safeti
triclosan
evalu
human
volunt
littl
indic
toxic
sensit
inform
human
chronic
usag
person
care
product
avail
benchmark
dose
bmdl
mgkgday
develop
base
kidney
toxic
hamster
estim
amount
intak
use
repres
person
care
product
men
women
children
deriv
two
way
use
known
assum
triclosan
level
variou
consum
product
assum
usag
pattern
productbas
estim
b
use
upper
bound
measur
urinari
triclosan
level
human
volunt
biomonitoringbas
estim
use
data
center
diseas
control
prevent
productbas
estim
margin
safeti
mo
combin
exposur
estim
intak
use
triclosancontain
product
consid
approxim
men
women
children
respect
mo
calcul
biomonitoringbas
estim
intak
men
women
children
respect
base
result
exposur
triclosan
consum
product
expect
caus
advers
health
effect
children
adult
use
product
intend
triclosan
test
total
trial
oral
health
three
trial
mrsa
trial
relat
surgeri
wound
stent
list
clinicaltrialsgov
date
data
effect
triclosan
oral
health
outcom
clear
triclosan
copolym
dentifric
contain
triclosan
copolym
fluorid
ppm
f
colgat
total
colgatepalmol
compani
nj
usa
maintain
concentr
triclosan
plaqu
exceed
minimum
inhibitori
concentr
mic
valu
mani
plaqu
bacteria
h
numer
random
control
clinic
trial
review
shown
signific
efficaci
triclosan
copolym
dentifric
reduc
plaqu
improv
gingiv
health
peridonat
diseas
triclosan
zinc
citrat
dentifric
also
shown
excel
efficaci
gingiv
health
respect
mrsa
one
observ
report
found
addit
triclosan
soap
instrument
contain
outbreak
mrsa
neonat
nurs
unit
prevent
recurr
year
studi
uk
suggest
widespread
commerci
use
significantli
increas
rate
resist
triclosan
consid
potenti
use
adjuv
topic
agent
optim
treatment
plan
aggress
decolon
mrsa
yet
undefin
systemat
literatur
review
assess
studi
publish
examin
efficaci
product
contain
triclosan
compar
plain
soap
commun
set
well
evalu
emerg
antibioticresist
bacteria
soap
contain
triclosan
within
rang
concentr
commonli
use
commun
set
wtvol
effect
plain
soap
prevent
infecti
ill
symptom
reduc
bacteri
level
hand
sever
laboratori
studi
demonstr
evid
triclosanadapt
crossresist
antibiot
among
differ
speci
bacteria
author
suggest
lack
addit
health
benefit
associ
use
triclosancontain
consum
soap
regular
soap
coupl
laboratori
data
demonstr
potenti
risk
select
drug
resist
warrant
evalu
government
regul
regard
antibacteri
product
claim
advertis
global
infecti
diseas
burden
decreas
dramat
standard
live
increas
improv
medic
care
access
around
world
concurr
global
popul
get
fatter
fatter
diet
exercis
alon
explain
rise
obes
partial
attribut
absenc
infect
studi
examin
whether
decreas
infecti
diseas
load
associ
increas
growth
measur
heightforweight
addit
data
growth
infecti
diseas
load
affect
divers
microbiom
peopl
detail
growth
infecti
diseas
load
affect
immun
system
respons
young
children
less
spars
greater
understand
relationship
would
help
studi
provid
inform
factor
relat
numer
antibacteri
product
wide
commerci
avail
presum
ultim
goal
reduc
infect
use
howev
evid
product
measur
effect
infecti
diseas
incid
addit
impact
product
may
gut
microbiom
unknown
studi
examin
whether
exposur
antimicrobi
triclosan
associ
decreas
incid
infect
within
household
also
examin
whether
triclosan
exposur
associ
decreas
microbi
divers
peopl
decreas
breadth
immun
system
respons
specif
studi
cohort
compris
babi
born
low
risk
primarili
low
incom
women
local
resid
san
francisco
bay
area
mostli
hispan
recent
immigr
origin
low
incom
famili
suffer
disproportion
infect
due
increas
likelihood
crowd
women
household
also
like
expos
triclosan
occup
houseclean
thu
may
particularli
interest
studi
hypothesi
popul
could
benefit
ad
inform
studi
make
access
furthermor
relationship
examin
studi
sampl
repres
billion
individu
worldwid
total
pregnant
women
undergo
one
blood
draw
venipunctur
two
fingerstick
pregnanc
alreadi
part
prenat
care
infant
undergo
annual
blood
draw
total
three
everyfourmonth
heel
stick
total
six
small
risk
bruis
venipunctur
precaut
taken
infect
site
phlebotomi
quit
rare
effort
made
prevent
complic
use
train
phlebotomist
great
attent
steril
techniqu
faint
occur
phlebotomi
adult
risk
minim
identifi
patient
faint
previous
requir
lie
phlebotomi
other
without
histori
blood
drawn
sit
posit
monitor
complaint
sign
lightheaded
blood
draw
volum
within
guidelin
healthi
adult
ageappropri
infant
women
may
consid
vulner
popul
due
languag
barrier
well
factor
relat
econom
social
resettl
potenti
anxieti
immigr
statu
studi
personnel
made
cogniz
anxieti
attend
immigr
put
undu
pressur
particip
potenti
particip
precaut
taken
part
consent
process
insur
commun
facil
well
understand
health
need
benefit
affect
particip
nonparticip
studi
see
appendix
consent
form
requir
subject
abl
commun
effect
spanish
english
form
translat
spanish
spanish
speak
subject
test
comprehens
spanish
english
administ
end
inform
consent
process
ensur
understand
see
appendix
test
comprehens
unclear
whether
triclosan
neg
health
effect
clear
remov
triclosan
product
toothpast
health
risk
unknown
whether
continu
use
triclosancontain
product
alreadi
present
home
environ
risk
health
famili
long
health
term
risk
prolong
treatment
shortterm
advers
effect
small
confidenti
risk
use
mobil
phone
contact
particip
weekli
basi
weekli
health
statu
report
essenti
aspect
studi
secur
risk
particip
identifi
mobil
phone
number
low
altern
data
gather
procedur
consid
consid
particip
given
option
use
email
altern
provid
weekli
updat
sampl
compris
primarili
immigr
women
whose
lower
socioeconom
statu
lower
literaci
rate
low
incom
gener
may
allow
regular
access
internet
email
updat
health
statu
women
small
children
often
mobil
phone
focu
group
discuss
studi
indic
willing
respond
weekli
telephon
survey
unclear
whether
triclosan
neg
health
benefit
human
unknown
whether
remov
triclosan
home
environ
benefit
health
famili
triclosancontain
product
tend
cost
product
contain
triclosan
clear
understand
whether
increas
cost
product
associ
benefit
would
assist
famili
concern
budget
societ
perspect
better
knowledg
infect
host
immun
respons
affect
bodi
habitu
may
lead
effect
prevent
treatment
strategi
object
determin
associ
infecti
diseas
load
utero
age
year
measur
sickday
growth
measur
heightforweight
zscore
b
determin
whether
exposur
antimicrobi
triclosan
measur
intervent
arm
decreas
infecti
diseas
load
measur
assess
associ
infect
microbi
divers
character
microbiota
rrna
gene
sequenc
analysi
assess
associ
infect
breadth
develop
immun
system
respons
measur
type
proport
effector
memori
central
memori
cell
assess
associ
growth
microbi
divers
assess
associ
growth
breadth
develop
immun
system
respons
assess
associ
triclosan
exposur
microbi
divers
assess
associ
triclosan
exposur
breadth
develop
immun
system
respons
observ
cohort
studi
recruit
pregnant
women
follow
infant
utero
birth
three
year
goal
assess
infecti
diseas
burden
chang
growth
rest
metabol
rate
immun
system
develop
microbiom
develop
mother
report
infecti
condit
pregnanc
report
health
statu
babi
weekli
basi
deliveri
everi
six
month
height
weight
measur
infecti
diseas
diagnos
treatment
development
mileston
obtain
pediatr
record
everi
four
month
temperatur
weight
saliva
sampl
skin
swab
environment
sampl
taken
blood
drawn
assess
cumul
presenc
antibodi
infecti
agent
annual
marker
immun
system
develop
examin
rest
metabol
rate
measur
addit
divers
microbiom
assess
time
monthli
stool
sampl
superimpos
cohort
studi
random
intervent
remov
triclosancontain
clean
product
household
goal
correl
presenc
absenc
triclosan
infecti
diseas
burden
microbiom
divers
firstborn
children
decreas
risk
infect
greater
risk
increas
weight
gain
random
stratifi
firstborn
statu
gener
equal
proport
mother
firstborn
children
trial
arm
household
person
clean
product
provid
particip
everi
four
month
urinari
concentr
triclosan
assess
everi
four
month
infant
annual
mother
primari
outcom
cohort
studi
growth
measur
heightforweight
zscore
determin
whether
associ
exist
heightforweight
zscore
adjust
age
sex
infecti
diseas
load
primari
outcom
intervent
incid
infect
measur
cumul
sickday
utero
age
three
year
determin
whether
associ
exist
intervent
arm
sickday
adjust
diseas
sever
key
secondari
endpoint
includ
microbi
divers
character
rrna
gene
sequenc
analysi
breadth
develop
immun
system
respons
measur
type
proport
effector
memori
central
memori
cell
studi
sampl
enrol
popul
pregnant
women
attend
stanfordrel
obstetr
clinic
first
antenat
visit
woman
follow
throughout
pregnanc
babi
follow
first
three
year
babi
life
possibl
seek
enrol
women
primarili
lower
se
hispan
immigr
origin
infecti
condit
known
common
famili
crowd
high
famili
lower
se
tend
live
crowd
condit
addit
hispan
immigr
famili
like
incur
infect
preval
countri
origin
eg
h
pylori
furthermor
local
area
lower
se
hispan
ethnic
associ
increas
risk
obes
adult
possibl
oversampl
commun
may
lead
insuffici
variat
incid
infect
famili
incur
high
load
infect
also
possibl
due
high
background
rate
obes
commun
sampl
may
result
high
proport
infant
elev
bmi
sex
age
subject
undergo
assess
inclus
exclus
criteria
review
studi
personnel
prior
inclus
cohort
subject
must
meet
follow
inclus
criteria
particip
studi
abl
provid
written
inform
consent
abl
commun
effect
verbal
english
spanish
test
comprehens
studi
includ
subject
part
consent
process
femal
adult
year
age
within
first
two
trimest
week
pregnanc
will
provid
blood
saliva
urin
stool
specimen
will
provid
blood
saliva
urin
stool
specimen
infant
will
provid
consent
review
primari
provid
medic
record
regard
mother
medic
histori
infecti
condit
pregnanc
infant
apgar
score
height
weight
measur
birth
time
infecti
diseas
diagnos
treatment
vaccin
record
subject
meet
follow
exclus
criteria
exclud
studi
particip
one
fetu
high
risk
pregnanc
intent
move
bay
area
within
three
year
enrol
condit
opinion
pi
would
make
subject
unaccept
candid
studi
studi
particip
mani
concurr
enrol
anoth
research
studi
may
choos
enrol
anoth
studi
particip
studi
discret
approv
pi
termin
criteria
women
miscarri
fetu
consid
termin
studi
replac
children
die
remov
famili
reason
within
first
six
month
life
replac
die
remov
within
subsequ
two
one
half
year
followup
consid
termin
studi
replac
studi
popul
drawn
commun
east
palo
alto
east
menlo
park
san
mateo
counti
san
jose
santa
clara
counti
recruit
particip
public
obstetr
clinic
first
subsequ
prenat
visit
obstetr
clinic
agre
particip
date
lucil
packard
children
hospit
lpch
stanford
ca
santa
clara
valley
medic
center
scvmc
tulli
road
clinic
san
jose
ca
clinic
provid
referr
pool
enrich
toward
enrol
target
includ
high
proport
hispan
foreignborn
women
countri
infect
endem
women
interest
studi
base
queri
clinician
clinic
staff
contact
stanford
personnel
screen
elig
invit
particip
enrol
subject
provid
free
household
person
clean
product
everi
month
part
intervent
compens
particip
includ
everi
visit
gift
card
one
sever
local
store
safeway
target
andor
walmart
given
studi
approv
stanford
irb
consid
inher
ethic
low
risk
correspondingli
good
posit
benefitrisk
ratio
small
amount
money
consid
coerciv
undu
induc
even
immigr
group
provid
inform
consent
appropri
obtain
altern
incent
may
includ
voucher
local
farmer
market
particip
receiv
gift
card
everi
weekli
survey
complet
seri
present
clinician
local
clinic
plan
short
talk
topic
interest
studi
sampl
clinic
popul
overview
infecti
diseas
childhood
draft
recruit
form
found
appendix
household
person
clean
product
avail
high
volum
commerci
retail
deliv
home
two
list
one
item
one
item
contain
triclosan
gener
avail
merchandis
follow
categori
household
clean
product
hand
dishwash
deterg
person
care
product
hand
soap
bar
soap
toothpast
particip
provid
appropri
list
nontriclosan
contain
product
select
item
sent
household
quarterli
basi
need
categori
review
regular
basi
new
item
studi
staff
awar
whether
contain
triclosan
product
contain
triclosan
acquir
studi
formul
packag
label
origin
manufactur
modif
studi
product
contain
triclosan
acquir
studi
obtain
high
volum
commerci
retail
eg
safeway
maintain
highqual
suppli
chain
particip
decid
product
meet
reason
standard
stabil
storag
product
replac
product
contain
triclosan
provid
particip
choos
select
product
use
product
per
individu
product
label
discret
particip
product
provid
particip
assumpt
product
use
within
household
household
member
assumpt
reason
use
product
replac
quarterli
need
case
excess
amount
product
use
household
studi
coordin
assess
whether
use
justifi
particip
free
use
use
product
provid
studi
concomit
medic
procedur
beyond
random
triclosan
nontriclosan
contain
clean
product
use
studi
one
known
health
benefit
triclosan
posit
effect
gingiv
peridont
diseas
requir
household
random
nontriclosan
arm
remov
triclosancontain
toothpast
home
medic
procedur
consid
precautionari
prohibit
triclosan
administ
dose
studi
simpli
present
particip
individu
environ
work
home
unknown
amount
advers
event
due
triclosan
exposur
identifi
prophylact
medic
procedur
requir
triclosan
administ
dose
studi
simpli
present
particip
individu
environ
work
home
unknown
amount
advers
event
due
triclosan
exposur
identifi
rescu
medic
requir
inform
collect
record
train
studi
personnel
use
standard
pretest
form
either
paper
electron
see
appendix
c
questionnair
detail
sequenc
procedur
evalu
see
section
studi
schedul
appendix
schedul
assess
evalu
studi
either
intervieweradminist
questionnair
selfreport
respons
via
telephon
email
survey
chart
abstract
laboratori
find
biolog
environment
specimen
measur
temperatur
weight
rest
metabol
rate
assess
questionnair
questionnair
cover
follow
inform
patient
demograph
famili
structur
household
size
sibship
structur
birth
order
countri
origin
time
us
level
educ
obtain
particip
outofhom
child
care
measur
crowd
assess
household
cleanli
weekli
report
health
statu
pregnanc
mother
infant
health
statu
deliveri
chart
abstract
primari
provid
medic
record
abstract
includ
data
mother
pregnanc
prepregn
weight
weight
gain
time
reproduct
histori
chronic
condit
treatment
infecti
diseas
diagnos
treatment
diagnos
treatment
babi
deliveri
apgar
score
height
weight
complic
birth
visit
wellbabi
unschedul
height
weight
vaccin
histori
infecti
diseas
diagnos
treatment
diagnos
treatment
development
mileston
specimen
specimen
collect
mother
infant
includ
mother
blood
stool
saliva
armfold
skin
swab
urin
amniot
fluid
avail
cord
blood
deliveri
child
blood
stool
saliva
urin
armpit
skin
swab
sampl
also
collect
babi
sleep
place
kitchen
counter
weight
rest
metabol
rate
procedur
use
studi
includ
blood
draw
phlebotomi
use
collect
blood
sampl
mother
baselin
infant
annual
finger
prick
use
collect
sampl
mother
twice
prior
deliveri
heel
stick
use
collect
sampl
infant
everi
four
month
except
annual
blood
draw
stool
collect
mother
provid
kit
instruct
collect
stool
store
sampl
transport
laboratori
process
indirect
calorimetri
indirect
calorimetri
use
measur
rest
metabol
rate
measur
mother
deliveri
father
three
time
infant
month
see
appendix
mop
weight
weight
infant
taken
everi
four
month
use
portabl
scale
see
appendix
mop
saliva
collect
saliva
collect
everi
four
month
babi
mother
armpit
swab
skin
swab
armpit
collect
everi
four
month
babi
armfold
mother
laboratori
evaluationsassay
tabl
outlin
specimen
collect
laboratori
evalu
conduct
refer
rang
includ
mop
see
appendix
follow
assay
done
parsonnet
lab
within
hour
draw
sampl
crp
esr
detail
assay
discuss
assay
done
research
laboratori
includ
adipocytokin
interferon
gamma
leptin
ghrelin
glucagon
sampl
batch
ship
dri
ice
eve
technolog
custom
luminex
kit
run
serum
triclosan
test
urin
sampl
perform
stanford
sampl
batch
store
analyz
test
environment
sampl
dust
swab
perform
wood
institut
stanford
stool
saliva
vaginalrect
swab
pcrproduct
batch
ship
dri
ice
environment
genom
core
facil
engencor
univers
south
carolina
appropri
facil
store
analyz
antibodi
tbd
blood
sampl
collect
qualifi
phlebotomist
accord
standard
procedur
precaut
blood
draw
take
place
end
interview
sampl
label
uniqu
id
date
collect
tube
place
cooler
transport
parsonnet
lab
blood
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
tube
spun
g
x
minut
separ
plasma
serum
serum
plasma
aliquot
ul
store
futur
test
stool
sampl
collect
empti
wide
mouth
ml
contain
monthli
babi
mother
everi
month
mother
mother
particip
receiv
kit
stool
collect
kit
includ
one
contain
pre
label
uniqu
id
collect
date
one
paper
hat
tongu
suppressor
instruct
sampl
collect
mail
babi
particip
receiv
kit
stool
collect
mail
sampl
collect
diaper
soil
day
use
tongu
suppressor
swab
g
stool
transfer
diaper
wide
mouth
contain
pre
label
uniqu
id
collect
date
month
stork
studi
team
visit
particip
diaper
retain
stool
collect
studi
team
sampl
place
cooler
transport
parsonnet
lab
stool
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
receiv
stool
sampl
transfer
ml
cryovial
store
futur
use
gener
pcr
product
frozen
stool
sampl
ground
liquid
n
suspend
frozen
solut
contain
dna
extract
buffer
sd
mixtur
phenol
chloroform
isoamyl
alcohol
slurri
zirconiasilica
bead
microbi
cell
lyse
mechan
disrupt
bead
beater
follow
extract
phenol
chloroform
isoamyl
alcohol
precipit
isopropanol
quantiti
qualiti
purifi
dna
assess
rrna
gene
amplifi
sampl
pcr
product
store
ship
futur
analysi
particip
receiv
urin
collect
kit
includ
contain
urin
collect
bag
pediatr
instruct
collect
sampl
label
uniqu
id
date
collect
mother
particip
receiv
kit
urin
collect
sampl
prelabel
uniqu
id
date
collect
babi
sampl
collect
use
pediatr
urin
collect
kit
day
urin
transfer
contain
pre
label
uniqu
id
collect
date
sampl
place
cooler
transport
parsonnet
lab
urin
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
minimum
ml
urin
transfer
specimen
vial
within
hour
collect
poli
propylen
vial
crimp
cap
rubber
stopper
use
composit
specimen
label
frozen
immedi
ask
particip
place
steril
swab
mouth
short
time
swab
becom
soak
saliva
process
repeat
swab
well
soak
saliva
way
swab
place
babi
mouth
swab
place
tube
storag
solut
tube
label
uniqu
id
date
collect
tube
place
cooler
transport
parsonnet
lab
swab
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
swab
sampl
store
futur
use
pcr
product
gener
babi
armpit
swab
cottontip
swab
moisten
solut
nacl
tween
tube
label
uniqu
id
date
collect
tube
place
cooler
transport
parsonnet
lab
swab
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
swab
sampl
store
futur
use
pcr
product
gener
household
cm
squar
area
babi
bed
swab
cotton
tip
swab
moisten
solut
nacl
tween
tube
label
uniqu
id
date
collect
tube
place
cooler
transport
parsonnet
lab
swab
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
swab
sampl
store
futur
use
household
cm
squar
area
kitchen
countertop
swab
cotton
tip
swab
moisten
solut
nacl
tween
tube
label
uniqu
id
date
collect
tube
place
cooler
transport
parsonnet
lab
swab
sampl
log
parsonnet
lab
uniqu
id
date
collect
initi
person
receiv
swab
sampl
store
futur
use
pcr
product
gener
schedul
assess
studi
see
appendix
c
describ
detail
section
potenti
particip
invit
obstetr
clinic
staff
contact
stork
studi
staff
studi
screen
enrol
take
place
obstetr
clinic
explain
studi
object
procedur
inclus
exclus
criteria
appli
elig
particip
consid
enrol
potenti
particip
may
screenedenrol
home
prefer
enrol
occur
time
locat
screen
test
comprehens
administ
inform
consent
studi
particip
obtain
subject
given
contact
inform
studi
copi
inform
consent
blood
tablespoon
urin
saliva
sampl
taken
structur
interview
administ
famili
structur
inform
includ
household
size
sibship
sizebirth
order
etc
stool
vial
dispens
later
collect
return
laboratori
deliveri
particip
contact
weekli
ask
infecti
condit
may
experienc
case
amniocentesi
perform
sampl
drop
amniot
fluid
obtain
antibodi
determin
earli
enrol
later
gestat
week
week
schedul
clinic
prenat
visit
small
volum
blood
obtain
antibodi
determin
either
finger
stick
half
teaspoon
addit
volum
case
routin
blood
draw
tablespoon
review
medic
record
prepregn
weight
pariti
histori
chronic
condit
gestat
diabet
infect
ill
occur
pregnanc
perform
part
routin
care
vaginalrect
swab
collect
week
visit
addit
swab
collect
studi
censu
triclosancontain
product
household
taken
cord
blood
collect
drop
chart
review
perform
babi
apgar
score
birth
weight
height
complic
ofat
deliveri
weekli
particip
contact
weekli
assess
health
statu
infant
within
past
week
use
structur
phonebas
questionnair
mother
ask
identifi
infecti
symptom
antibiot
use
appetit
level
medic
care
access
stool
sampl
babi
collect
mother
use
specif
kit
sent
stanford
studi
staff
visit
particip
home
everi
four
month
time
questionnair
administ
updat
inform
chang
household
addit
babi
weight
assess
heel
stick
draw
blood
drop
saliva
obtain
swab
taken
skin
arm
urin
sampl
taken
mother
provid
kit
monthli
stool
sampl
collect
microbiom
assess
babi
similar
sampl
obtain
mother
stool
urin
saliva
skin
swab
environment
sampl
collect
babi
sleep
place
counter
kitchen
assess
cleanli
home
perform
clean
product
replenish
time
particip
receiv
gift
card
end
everi
visit
abstract
pediatrician
record
child
height
weight
ill
treatment
vaccin
development
mileston
perform
singl
measur
matern
patern
rest
metabol
rate
use
indirect
calorimetri
taken
child
rest
metabol
rate
use
indirect
calorimetri
measur
three
time
three
year
prefer
month
age
annual
visit
blood
sampl
drawn
mother
tablespoon
babi
teaspoon
final
studi
visit
last
annual
visit
reason
earli
termin
includ
studi
particip
longer
meet
inclusionexclus
criteria
studi
particip
withdraw
consent
studi
particip
lost
followup
studi
termin
earli
termin
visit
subject
may
withdraw
voluntarili
particip
studi
time
advers
event
ae
untoward
medic
occurr
subject
undergo
studi
relat
procedur
believ
reason
caus
studi
relat
procedur
ae
aris
studi
procedur
may
includ
bruis
faint
phlebotomi
studyrel
ae
anticip
consid
ae
event
must
occur
within
hour
phlebotomi
sae
untoward
medic
occurr
result
death
lifethreaten
advers
experi
place
subject
view
investig
immedi
risk
death
reaction
occur
ie
includ
reaction
occur
seriou
form
might
caus
death
requir
inpati
hospit
prolong
exist
hospit
result
persist
signific
disabl
incapac
congenit
anomalybirth
defect
requir
intervent
prevent
perman
impair
damag
import
medic
event
result
death
lifethreaten
requir
hospit
may
consid
seriou
advers
event
base
upon
appropri
medic
judgment
might
jeopard
subject
might
requir
medic
surgic
intervent
prevent
one
outcom
list
primari
health
care
provid
care
patient
studi
given
stanford
irb
case
report
form
use
clinic
examin
seriou
event
report
pi
stanford
irb
dedic
case
report
form
accord
stanford
univers
irb
polici
anticip
sae
studi
consid
unexpect
sae
event
must
occur
within
hour
phlebotomi
event
meet
previous
describ
definit
sae
complet
stanford
irb
seriou
advers
event
case
report
form
requir
inform
begin
collect
first
subject
encount
one
month
follow
last
subject
encount
specif
inform
send
form
includ
mop
studi
see
appendix
sae
record
appropri
seriou
advers
event
case
report
form
review
irb
need
studi
pi
complet
seriou
advers
event
form
within
follow
timelin
death
whether
associ
associ
sae
occur
one
hour
follow
blood
draw
record
seriou
advers
event
form
sent
fax
within
hour
site
awar
sae
death
immedi
lifethreaten
event
regardless
relationship
report
via
fax
site
within
hour
becom
awar
event
sae
follow
satisfactori
resolut
pi
deem
event
chronic
patient
stabl
pi
inform
nih
local
irb
death
sae
lifethreaten
problem
occur
studi
studi
util
data
safeti
monitor
board
dsmb
safeti
monitor
committe
smc
pregnanc
key
inclus
criterion
studi
pregnanc
confirm
studi
index
mother
becom
pregnant
second
time
enrol
studi
particip
continu
studi
new
babi
follow
find
mother
pregnant
second
time
consid
separ
find
particip
collect
laboratori
data
limit
laboratori
paramet
relev
studi
outcom
measur
andor
clinic
outcom
laboratori
data
collect
within
studi
includ
level
tnf
grehlin
insulin
leptin
ifngamma
igf
glucagon
resistin
plasminogen
activ
inhibitor
crp
esr
lp
triclosan
addit
microbi
antibodi
microbi
divers
assess
treatment
provid
part
studi
laboratori
measur
treatment
safeti
conduct
toxic
tabl
defin
sae
anticip
phlebotomi
minor
advers
event
faint
bruis
sight
phlebotomi
may
occur
ae
subject
given
research
offic
number
call
concern
event
subject
call
within
hour
follow
report
advers
event
medic
followup
identifi
necessari
followup
continu
ae
resolv
given
essenti
observ
natur
studi
priori
expect
sae
identifi
sae
review
real
time
pi
one
seriou
relat
sae
trigger
suspens
studi
pi
review
ae
occur
studi
particular
focu
sae
review
may
result
protocol
chang
precautionari
decis
includ
modif
consent
form
suspens
protocol
necessari
greater
one
relat
sae
strongli
consid
ground
halt
studi
nonseri
ae
review
pi
weekli
basi
determin
relat
event
studi
procedur
made
addit
review
advers
event
report
receipt
irb
review
advers
event
case
report
annual
protocol
review
reason
halt
studi
may
includ
new
inform
render
protocol
uneth
failur
meet
enrol
target
remedi
step
taken
chang
research
prioriti
fund
constraint
pi
nih
possibl
intervent
aspect
studi
could
halt
leav
cohort
aspect
ongo
reason
halt
intervent
aspect
includ
new
inform
render
studi
triclosan
uneth
inabl
detect
differ
triclosan
level
household
chang
research
prioriti
fund
constraint
pi
nih
particip
right
stop
particip
studi
time
case
prematur
withdraw
particip
studi
attempt
made
complet
termin
visit
mother
infant
pair
particip
locat
two
month
drop
studi
particip
mother
drop
studi
still
enrol
particip
prior
birth
child
replac
particip
motherchild
pair
drop
within
two
month
final
cohort
particip
enrol
replac
particip
motherchild
pair
drop
three
month
final
cohort
particip
enrol
pair
replac
pi
respons
daytoday
monitor
studi
activ
review
studi
activ
recruit
object
protocol
complianc
data
document
integr
studi
personnel
weekli
basi
avail
question
problem
time
ensur
inform
consent
appropri
obtain
subject
addit
see
resourc
appropri
alloc
studi
personnel
adequ
supervis
suppli
pi
respons
ensur
appropri
communicationsinclud
data
record
reportsar
transmit
irb
coinvestig
time
manner
monitor
conduct
pi
also
respons
ensur
monitor
find
bodi
requir
action
address
studi
carri
stanford
univers
support
collabor
referr
arrang
clinic
particip
studi
recruit
procedur
approv
stanford
univers
irb
scvmc
irb
human
subject
protect
ensur
annual
irb
review
stanford
scvmc
although
recruit
site
use
stanford
personnel
recruit
subject
collect
studi
inform
manag
sampl
data
health
care
provid
clinic
site
refer
appropri
subject
stanford
personnel
recruit
keep
personnel
recruit
site
inform
inservic
workshop
conduct
recruit
site
provid
orient
materi
develop
standard
recruit
form
develop
semiannu
meet
schedul
site
report
studi
progress
discuss
studi
relat
issu
recruit
followup
arrang
studi
staff
present
particip
clinic
least
one
day
per
week
troubleshoot
well
followup
recruit
pi
review
ae
respons
identifi
appropri
medic
resourc
respond
ae
need
data
safeti
monitor
board
dsmb
safeti
monitor
committe
smc
anticip
studi
cohort
studi
infant
follow
utero
age
year
primari
object
determin
associ
infecti
diseas
load
measur
cumul
sickday
growth
measur
heightforweight
zscore
random
intervent
nest
within
cohort
primari
object
determin
whether
exposur
triclosan
measur
intervent
arm
decreas
infecti
diseas
load
account
dropout
rate
per
year
expect
children
complet
full
three
year
cohort
studi
secondari
analys
cohort
includ
assess
associ
infect
microbi
divers
character
microbiota
rrna
gene
sequenc
analysi
assess
associ
infect
breadth
develop
immun
system
respons
measur
type
proport
effector
memori
central
memori
cell
assess
associ
growth
microbi
divers
assess
associ
growth
breadth
develop
immun
system
respons
assess
associ
triclosan
exposur
microbi
divers
assess
associ
triclosan
exposur
breadth
develop
immun
system
respons
associ
specif
chronic
infect
eg
variou
herpesvirus
h
pylori
weight
gain
evalu
sequenc
infect
acquisit
subsequ
cytokin
respons
infecti
exposur
correl
frequenc
antibiot
use
growth
associ
infect
metabol
rate
acut
chronic
evalu
durat
matern
antibodi
infant
although
common
wisdom
maintain
antibodi
persist
six
month
actual
data
matern
antibodi
vari
describ
small
number
infecti
diseas
descript
epidemiolog
childhood
infect
surprisingli
incid
mani
infect
childhood
includ
skin
infect
streptococc
pharyng
diarrheal
diseas
mani
common
ill
larg
unknown
evalu
associ
infect
common
childhood
diseas
asthma
juvenil
onset
diabet
evalu
effect
episod
fever
microbiom
wide
varieti
clinic
measur
collect
studi
either
primari
exposur
measur
primari
outcom
interest
potenti
confound
relationship
consid
compon
metabol
pathway
explor
exposur
measur
includ
report
infecti
diseaselik
symptom
temperatur
microbi
seroconvers
number
organ
age
onset
chronic
specif
infect
sequenc
infect
acquisit
outcom
measur
includ
interv
chang
anthropomorph
measur
visit
confound
includ
diet
activ
obes
famili
famili
structur
element
etiolog
pathway
includ
metabol
rate
adipocytokin
cytokin
analyt
role
measur
specifi
tabl
studi
analysi
plan
written
prior
databas
final
close
test
assum
confid
power
distribut
test
normal
nonparametr
test
use
case
nonnorm
primari
hypothesi
distribut
heightforweight
zscore
differ
high
low
infecti
diseas
load
group
outcom
zscore
predictor
day
ill
categor
high
low
load
base
distribut
sickday
analysi
ttest
group
use
multipl
regress
look
potenti
confound
effect
modifi
diagnost
valid
zscore
approach
random
intercept
model
descript
statist
provid
infecti
diseas
load
specif
combin
infect
individu
infect
incid
seroconvers
overal
specif
infect
present
varieti
time
point
statist
age
onset
chronic
specif
infect
calcul
sequenc
acquisit
infect
gener
descript
statist
provid
primari
growth
variabl
includ
heightforweight
heightforag
weightforag
comparison
summari
zscore
statist
sampl
appropri
refer
popul
perform
descript
statist
immun
respons
variabl
appropri
combin
provid
sequenc
gener
pyrosequenc
barcod
rrna
gene
pcr
amplicon
analyz
use
open
sourc
softwar
packag
quantit
insight
microbi
ecolog
qiim
rrna
gene
sequenc
assign
oper
taxonom
unit
otu
use
uclust
threshold
pairwis
ident
classifi
taxonom
use
ribosom
databas
project
rdp
classifi
treebas
analys
singl
repres
sequenc
otu
align
use
pynast
phylogenet
tree
built
use
fasttre
phylogenet
tree
use
measur
adivers
phylogenet
divers
pd
bdivers
use
unweight
unifrac
sampl
nearest
shrunken
centroid
method
use
identifi
otu
specif
repres
given
categori
amount
shrinkag
chosen
order
minim
overal
misclassif
error
analysi
perform
use
pamr
predict
analysi
microarray
packag
r
softwar
associ
infecti
diseas
load
growth
immun
respons
microbiom
respons
consid
take
consider
confound
etiolog
pathway
appropri
subject
lost
followup
includ
time
seri
analys
censor
factor
associ
lossto
followup
evalu
systemat
bias
subject
drop
replac
roll
recruit
month
last
particip
enrol
examin
pattern
miss
data
identifi
potenti
systemat
bias
sensit
analys
conduct
assess
influenc
miss
data
studi
result
analysi
intend
alloc
intenttotreat
perprotocol
analys
plan
cumul
incid
incid
densiti
infecti
diseas
load
time
calcul
addit
analys
consid
specif
type
group
diseas
eg
upper
respiratori
vs
diarrheal
specif
infect
cox
regress
use
compar
intervent
arm
take
time
consider
adjust
potenti
confound
effect
modifi
eg
crowd
daycar
exposur
etc
associ
studi
arm
microbi
divers
explor
associ
studi
arm
immun
system
develop
section
precis
data
regard
infecti
diseas
burden
load
rare
upper
respiratori
infect
uri
infant
toddler
thought
occur
approxim
time
per
year
last
approxim
week
estim
day
uri
per
year
diarrheal
diseas
shown
last
less
week
childcar
day
approxim
affect
day
per
year
lead
cumul
total
uri
diarrhea
day
ill
per
year
assum
high
infecti
diseas
load
median
day
ill
per
year
low
infecti
diseas
load
one
day
less
fewer
median
day
ill
per
year
assum
refer
popul
gener
zscore
gener
base
popul
infecti
diseas
load
rel
high
thu
sampl
high
infecti
diseas
load
mean
zscore
assum
sampl
low
infecti
diseas
increas
mean
zscore
compar
refer
popul
given
alpha
power
tabl
sampl
pair
would
suffici
detect
differ
zscore
assum
common
standard
deviat
subject
per
arm
would
suffici
show
differ
zscore
standard
deviat
assum
one
year
triclosan
exposur
caus
differ
number
sickday
describ
given
alpha
power
tabl
infant
nontriclosan
household
sick
sd
day
one
year
total
subject
arm
suffici
detect
decreas
triclosan
exposur
subject
arm
allow
us
see
decreas
sick
day
attribut
triclosan
one
year
infant
nontriclosan
household
sick
sd
sd
day
random
pregnant
women
two
arm
clean
product
either
contain
triclosan
contain
triclosan
occur
enrol
school
medicin
data
coordin
center
dcc
special
plan
develop
manag
oper
system
studi
trial
gener
webbas
program
perform
bias
coin
random
allow
equal
distribut
across
trial
arm
case
first
born
children
nonfirstborn
children
studi
staff
access
program
time
enrol
full
document
maintain
dcc
studi
conduct
accord
procedur
identifi
protocol
paper
form
laboratori
report
review
studi
supervisor
approv
initi
prior
data
entri
electron
form
review
approv
initi
electron
signatur
pi
maintain
manual
procedur
mop
cover
site
recruit
screen
elig
criteria
data
sourc
laboratori
method
analys
studyspecif
protocol
see
appendix
mop
modif
document
date
rational
natur
modif
mop
use
orient
train
studi
staff
function
supervis
studi
coordin
field
laboratori
personnel
use
standard
oper
procedur
sop
manag
sampl
data
data
evalu
complianc
protocol
accuraci
relat
sourc
document
weekli
meet
pi
studi
staff
schedul
use
troubleshoot
refin
specif
procedur
orient
meet
held
referr
site
inservic
meet
schedul
least
semiannu
form
procedur
review
data
evalu
complianc
protocol
accuraci
relat
sourc
document
document
pilot
first
three
month
studi
field
check
consist
interpret
code
semiannu
thereaft
random
sampl
field
select
traceback
data
base
inform
hard
copi
field
check
supervis
studi
coordin
sql
queri
run
period
feedback
anomali
miss
data
appropri
control
util
laboratori
assay
everi
six
month
blind
control
sampl
submit
qaqc
test
laboratori
notebook
review
everi
six
month
freezer
storag
sampl
monitor
daili
pi
ensur
studi
conduct
full
conform
current
revis
declar
helsinki
intern
confer
harmonis
good
clinic
practic
ichgcp
regul
guidelin
whichev
afford
greater
protect
subject
consent
procedur
conform
declar
helsinki
accord
standard
stanford
univers
research
involv
human
subject
subject
confidenti
held
strictli
trust
pi
staff
recruit
clinic
sponsor
agent
confidenti
extend
cover
test
biolog
sampl
genet
test
addit
clinic
inform
relat
particip
subject
studi
data
inform
gener
held
strict
confid
inform
concern
studi
data
releas
unauthor
third
parti
without
prior
written
approv
stanford
univers
irb
nih
author
repres
nih
may
inspect
document
record
requir
maintain
pi
includ
limit
primari
provid
medic
record
offic
clinic
hospit
subject
studi
subject
inform
prior
consent
institut
author
individu
data
may
made
avail
inform
concern
data
releas
unauthor
third
parti
without
prior
written
approv
pi
subject
subject
inform
prior
consent
natur
person
inform
may
obtain
medic
chart
laboratori
test
also
inform
sampl
may
store
follow
complet
studi
futur
relat
research
name
forev
unlink
sampl
addit
subject
inform
result
research
studi
avail
parti
becom
part
primari
practition
medic
record
hipaa
author
approv
irb
stanford
univers
includ
appendix
part
consent
form
subject
assign
uniqu
anonym
studi
id
upon
referr
shall
serv
key
index
locat
subject
record
specimen
sampl
databas
passwordprotect
stanford
univers
institut
review
board
call
administr
panel
human
subject
medic
research
see
http
humansubjectsstanfordedu
review
continu
review
protocol
protocol
amend
advers
event
report
annual
updat
propos
amend
protocol
consent
materi
approv
place
use
irb
regist
ohrp
women
elig
enrol
age
year
greater
mother
consid
minor
women
provid
consent
infant
studi
current
time
studi
follow
infant
age
three
year
special
popul
particip
studi
includ
pregnant
women
women
hispan
origin
infant
exclus
requir
limit
enrol
individu
commun
effect
english
spanish
see
mop
inform
consent
process
initi
prior
individu
agre
particip
studi
continu
throughout
individu
studi
particip
discuss
risk
possibl
benefit
particip
studi
provid
subject
consent
form
describ
detail
studi
procedur
risk
given
subject
written
document
inform
consent
requir
prior
enrol
studi
consent
form
approv
irb
subject
ask
read
review
document
upon
review
document
investig
explain
research
studi
subject
answer
question
may
aris
follow
review
inform
consent
subject
ask
take
brief
test
comprehens
see
appendix
misunderstand
review
discuss
subject
opportun
take
unsign
form
home
discuss
famili
other
think
prior
agre
particip
subject
sign
inform
consent
document
prior
enrol
studi
subject
may
withdraw
consent
time
throughout
cours
studi
copi
inform
consent
document
given
subject
record
right
welfar
subject
protect
emphas
qualiti
medic
care
advers
affect
declin
particip
studi
consent
administ
languag
subject
profici
either
english
spanish
consent
occur
time
enrol
subject
inform
meet
enrol
criteria
enrol
cohort
studi
random
intervent
arm
thu
sign
consent
enrol
provid
sampl
sampl
test
sampl
conserv
possibl
futur
studi
follow
twice
pregnanc
follow
birth
child
three
year
contact
weekli
birth
child
provid
health
statu
inform
provid
sampl
blood
stool
saliva
urin
skin
swab
total
visit
child
test
indirect
calorimetri
mother
father
possibl
child
addit
ask
give
permiss
investig
obtain
select
inform
child
primari
provid
medic
record
pertain
assess
done
clinician
pediatrician
infecti
diseas
diagnos
treatment
height
weight
gain
development
mileston
vaccin
statu
consent
addit
ask
permiss
recontact
subject
addon
studi
consent
form
particip
given
opportun
choos
whether
specimen
may
kept
futur
unspecifi
research
unlink
name
identifi
inform
current
inform
consent
form
appendix
particip
free
discontinu
particip
studi
time
effort
made
understand
particip
chosen
discontinu
particip
studi
may
discontinu
time
pi
nih
stanford
univers
irb
residu
specimen
maintain
studi
complet
subject
consent
see
appendix
consent
form
store
specimen
unlink
person
identifi
complet
studi
sampl
store
stanford
univers
school
medicin
specimen
select
use
may
store
year
use
investig
relat
investig
futur
studi
review
stanford
univers
irb
data
manag
copi
dataset
provid
nih
complet
studi
time
request
nih
pi
maintain
complet
accur
document
studi
studi
employ
studi
coordin
data
manageranalyst
epidemiologiststatistician
supervis
pi
respons
develop
recordkeep
system
qualiti
audit
prepar
analyt
dataset
subject
hard
copi
file
sourc
materi
maintain
studi
offic
grant
build
stanford
school
medicin
file
uniqu
id
sourc
materi
primari
provid
medic
record
provid
electron
format
photocopi
studi
personnel
sourc
materi
includ
log
sheet
front
file
document
receipt
data
differ
sourc
action
taken
contact
sheet
contain
essenti
contact
inform
copi
consent
form
kept
lock
cabinet
offic
studi
coordin
sourc
materi
review
upon
receipt
studi
coordin
initi
consist
correct
prior
databas
entri
data
enter
electron
databas
ms
access
redcap
use
code
form
rang
logic
check
per
field
form
code
dictionari
instruct
use
electron
databas
contain
mop
laboratori
research
studi
includ
result
routin
blood
test
cytokin
panel
assess
antibodi
triclosan
level
urin
laboratori
conduct
research
studi
provid
output
excel
spreadsheet
templat
email
pi
studi
coordin
run
review
form
also
document
control
standard
standard
curv
reliabl
statist
follow
review
data
compil
studi
data
manageranalyst
import
studi
databas
plate
layout
sheet
maintain
laboratori
dedic
notebook
use
reconcili
question
aris
line
list
gener
past
excel
spreadsheet
transmitt
review
entri
databas
laboratori
perform
statist
includ
standard
curv
paramet
rsquar
log
file
link
batch
run
period
plot
time
detect
drift
laboratori
perform
analysi
microbiom
provid
output
raw
data
file
record
file
receiv
kept
pi
project
data
manageranalyst
respons
transmit
copi
electron
databas
fund
oversight
author
requir
end
studi
weekli
health
statu
updat
collect
telephon
autom
telephon
poll
person
result
latter
enter
directli
redcap
former
automat
collect
cv
file
interview
administ
questionnair
respons
enter
onto
electron
form
use
tablet
electron
data
transfer
redcap
enter
paper
form
doubl
data
entri
use
enter
data
redcap
inform
obtain
medic
chart
review
receiv
electron
file
document
standard
paper
form
deposit
subject
file
review
studi
coordin
clinic
laboratori
report
includ
refer
rang
individu
result
document
electron
stanford
clinic
laboratori
anoth
refer
laboratori
hardcopi
form
sent
pi
clinic
laboratori
result
fax
studi
offic
individu
standard
report
form
complet
serolog
cytokin
assay
run
batch
result
captur
automat
excel
spreadsheet
templat
email
pi
data
analyst
studi
coordin
review
result
microbiom
analysi
captur
automat
sequenc
raw
sff
file
run
bioinformat
pipelin
googl
qiim
follow
data
type
collect
interview
respons
closeend
comment
field
clinic
data
close
end
comment
field
medic
chart
abstract
field
closeend
comment
field
clinic
laboratori
report
stanford
clinic
laboratori
refer
laboratori
standard
report
form
test
quantit
qualit
result
laboratori
refer
rang
laboratori
pulmonari
function
output
indirect
calorimetri
excel
spreadsheet
templat
contain
test
standard
measur
product
respiratori
exchang
ratio
laboratori
immunolog
output
antibodi
detect
quantif
excel
spreadsheet
templat
either
standard
antigen
quantit
result
array
format
laboratori
cdc
output
triclosan
level
sequenc
output
microbiom
find
subject
assign
uniqu
anonym
studi
id
point
enrol
particip
babi
given
relat
id
code
number
retain
strictest
confidenti
questionnair
laboratori
specimen
electron
record
index
id
number
singl
research
employe
studi
coordin
pi
access
code
disclos
code
research
personnel
except
taskspecif
author
enabl
field
staff
identifi
medic
record
chart
review
place
followup
phone
call
particip
code
link
name
particip
studi
id
kept
lock
cabinet
within
research
space
pi
data
gather
studi
subject
includ
analysi
refer
id
number
contain
person
identifi
subject
studi
inform
remain
confidenti
among
investig
research
personnel
time
author
repres
regulatori
agenc
permit
examin
requir
applic
law
copi
record
purpos
qualiti
assur
review
audit
evalu
studi
safeti
progress
document
studi
includ
hard
copi
subject
file
blood
saliva
urin
stool
specimen
document
report
laboratori
test
hard
copi
file
contain
inform
contain
person
identifi
hard
copi
file
kept
lock
file
within
research
offic
grant
build
room
stanford
medic
school
supervis
studi
coordin
access
restrict
author
studi
personnel
requir
permiss
studi
coordin
inform
contain
person
identifi
kept
lock
file
separ
studi
sourc
document
addit
hard
copi
file
specimen
bank
account
batch
laboratori
output
prepar
excel
spreadsheet
templat
index
subject
code
date
file
dedic
laboratori
notebook
studi
laboratori
director
avail
upload
electron
databas
follow
review
studi
coordin
studi
creat
webbas
relat
databas
htmldb
also
use
redcap
biomed
studi
databas
develop
platform
particip
contact
inform
data
entri
audit
retriev
research
data
subject
time
laboratori
specimen
level
databas
maintain
restrict
access
privileg
differ
research
personnel
data
entri
govern
code
book
mop
reduc
code
error
data
manag
cost
intervieweradminist
questionnair
respons
enter
directli
electron
databas
approv
accuraci
particip
minim
error
data
entri
perform
twice
compar
data
manageranalyst
develop
rang
consist
check
program
clean
data
data
analyz
sa
version
tbd
individu
laboratori
report
need
studi
proceed
laboratori
test
antibodi
assess
microbiom
test
perform
batch
fashion
either
end
studi
conveni
affili
laboratori
receiv
inform
regard
subject
random
statu
result
thu
blind
studi
arm
final
analysi
point
current
set
year
final
followup
semiannu
report
prepar
document
studi
progress
includ
number
refer
elig
enrol
withdrawn
complet
studi
file
except
futur
use
consent
form
maintain
minimum
three
year
complet
studi
data
collect
analysi
databas
analyt
dataset
may
store
indefinit
electron
data
analys
intervent
follow
intenttotreat
format
particip
nontriclosan
arm
report
consist
use
triclosancontain
household
person
clean
product
arm
demonstr
high
urinari
blood
concentr
triclosan
includ
intent
treat
analysi
initi
random
protocol
deviat
tabul
residu
specimen
maintain
studi
complet
subject
consent
see
appendix
consent
form
store
specimen
unlink
person
identifi
complet
studi
sampl
store
stanford
univers
school
medicin
specimen
may
store
year
use
investig
relat
investig
futur
studi
review
stanford
univers
irb
key
find
studi
well
studi
design
expect
made
public
end
studi
author
public
includ
pi
collabor
addit
investig
repres
refer
clinic
offer
opportun
particip
manuscript
develop
authorship
individu
studi
subject
identifi
identifi
public
present
